Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Apr 2024. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
5315750018 | Product containing precisely pancreatic amylase 36 unit/1 milligram and pancreatic lipase 50 unit/1 milligram and pancreatic protease 2 unit/1 milligram gastro-resistant oral granules (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
5315751019 | Pancreatic amylase 36 unit/mg and pancreatic lipase 50 unit/mg and pancreatic protease 2 unit/mg gastro-resistant oral granules | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely pancreatic amylase 36 unit/1 milligram and pancreatic lipase 50 unit/1 milligram and pancreatic protease 2 unit/1 milligram gastro-resistant oral granules (clinical drug) | Is a | Pancreatic amylase and pancreatic lipase and pancreatic protease only product in oral dose form | true | Inferred relationship | Some | ||
Product containing precisely pancreatic amylase 36 unit/1 milligram and pancreatic lipase 50 unit/1 milligram and pancreatic protease 2 unit/1 milligram gastro-resistant oral granules (clinical drug) | Has manufactured dose form | Gastro-resistant oral granules (dose form) | true | Inferred relationship | Some | ||
Product containing precisely pancreatic amylase 36 unit/1 milligram and pancreatic lipase 50 unit/1 milligram and pancreatic protease 2 unit/1 milligram gastro-resistant oral granules (clinical drug) | Plays role | Digestant therapeutic role (role) | false | Inferred relationship | Some | ||
Product containing precisely pancreatic amylase 36 unit/1 milligram and pancreatic lipase 50 unit/1 milligram and pancreatic protease 2 unit/1 milligram gastro-resistant oral granules (clinical drug) | The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). | Pancreatic protease (substance) | true | Inferred relationship | Some | 1 | |
Product containing precisely pancreatic amylase 36 unit/1 milligram and pancreatic lipase 50 unit/1 milligram and pancreatic protease 2 unit/1 milligram gastro-resistant oral granules (clinical drug) | This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. | Pancreatic protease (substance) | true | Inferred relationship | Some | 1 | |
Product containing precisely pancreatic amylase 36 unit/1 milligram and pancreatic lipase 50 unit/1 milligram and pancreatic protease 2 unit/1 milligram gastro-resistant oral granules (clinical drug) | This attribute specifies the numerator unit for the concentration strength of a product. | Unit | true | Inferred relationship | Some | 1 | |
Product containing precisely pancreatic amylase 36 unit/1 milligram and pancreatic lipase 50 unit/1 milligram and pancreatic protease 2 unit/1 milligram gastro-resistant oral granules (clinical drug) | This attribute specifies the denominator unit for the concentration strength of a product. | mg | true | Inferred relationship | Some | 1 | |
Product containing precisely pancreatic amylase 36 unit/1 milligram and pancreatic lipase 50 unit/1 milligram and pancreatic protease 2 unit/1 milligram gastro-resistant oral granules (clinical drug) | The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). | Pancreatic lipase | true | Inferred relationship | Some | 2 | |
Product containing precisely pancreatic amylase 36 unit/1 milligram and pancreatic lipase 50 unit/1 milligram and pancreatic protease 2 unit/1 milligram gastro-resistant oral granules (clinical drug) | This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. | Pancreatic lipase | true | Inferred relationship | Some | 2 | |
Product containing precisely pancreatic amylase 36 unit/1 milligram and pancreatic lipase 50 unit/1 milligram and pancreatic protease 2 unit/1 milligram gastro-resistant oral granules (clinical drug) | This attribute specifies the numerator unit for the concentration strength of a product. | Unit | true | Inferred relationship | Some | 2 | |
Product containing precisely pancreatic amylase 36 unit/1 milligram and pancreatic lipase 50 unit/1 milligram and pancreatic protease 2 unit/1 milligram gastro-resistant oral granules (clinical drug) | This attribute specifies the denominator unit for the concentration strength of a product. | mg | true | Inferred relationship | Some | 2 | |
Product containing precisely pancreatic amylase 36 unit/1 milligram and pancreatic lipase 50 unit/1 milligram and pancreatic protease 2 unit/1 milligram gastro-resistant oral granules (clinical drug) | The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). | Pancreatic amylase | true | Inferred relationship | Some | 3 | |
Product containing precisely pancreatic amylase 36 unit/1 milligram and pancreatic lipase 50 unit/1 milligram and pancreatic protease 2 unit/1 milligram gastro-resistant oral granules (clinical drug) | This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. | Pancreatic amylase | true | Inferred relationship | Some | 3 | |
Product containing precisely pancreatic amylase 36 unit/1 milligram and pancreatic lipase 50 unit/1 milligram and pancreatic protease 2 unit/1 milligram gastro-resistant oral granules (clinical drug) | This attribute specifies the numerator unit for the concentration strength of a product. | Unit | true | Inferred relationship | Some | 3 | |
Product containing precisely pancreatic amylase 36 unit/1 milligram and pancreatic lipase 50 unit/1 milligram and pancreatic protease 2 unit/1 milligram gastro-resistant oral granules (clinical drug) | This attribute specifies the denominator unit for the concentration strength of a product. | mg | true | Inferred relationship | Some | 3 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets